MEthicillin-Susceptible Staphylococcus Aureus Nasal Colonization And The Risk Of Subsequent Methicillin-Resistant Staphylococcus Aureus Infections Among Hospitalized Patients

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 2, 2011, Pages 163-166

  Ruhe, Jörg J ^a   de Guzman, Leonidez ^a   Moss, Marie ^a   Riley, William ^a   Mildvan, Donna ^a   Perlman, David C ^a   Koll, Brian ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Hospitalized patients; MRSA; MSSA

Indexed keywords

BETA LACTAM ANTIBIOTIC; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM CULTURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FEMALE; HOSPITAL PATIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; NOSE; NOSE SMEAR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; CROSS INFECTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASAL CAVITY; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 80052841752     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.05.011     Document Type: Article

References (10)

1. Bisognano C., Vaudaux P.E., Lew D.P., Ng E.Y., Hooper D.C. Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 1997, 41:906-913.
2. Charbonneau P., Parienti J.J., Thibon P., Ramakers M., Daubin C., et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin. Infect. Dis. 2006, 42:778-784.
3. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chron. Dis. 1987, 40:373-383.
4. Davis K.A., Stewart J.J., Crouch H.K., Florez C.E., Hospenthal D.R. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin. Infect. Dis. 2004, 39:776-782.
5. Honda H., Krauss M.J., Coopersmith C.M., Kollef M.H., Richmond A.M., et al. Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: Does methicillin resistance matter?. Infect. Control Hosp. Epidemiol. 2010, 31:584-591.
6. Popovich K.J., Weinstein R.A., Aroutcheva A., Rice T., Hota B. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin. Infect. Dis. 2010, 50:979-987.
7. Safdar N., Bradley E.A. The risk of infection after nasal colonization with Staphylococcus aureus. Am. J. Med. 2008, 121:310-315.
8. Weber S.G., Gold H.S., Hooper D.C., Karchmer A.W., Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg. Infect. Dis. 2003, 9:1415-1422.
9. Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet. Infect. Dis. 2005, 5:751-762.
10. Wertheim H.F., Vos M.C., Ott A., van Belkum A., Voss A., et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004, 364:703-705.